Marchex, Inc. (NASDAQ:MCHX) Short Interest Down 35.6% in August

Marchex, Inc. (NASDAQ:MCHX) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 28,578 shares, a decrease of 35.6% from the August 15th total of 44,393 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 18,895 shares, the days-to-cover ratio is currently 1.5 days.

Marchex Stock Up 5.4%

Shares of NASDAQ MCHX traded up $0.07 during mid-day trading on Thursday, hitting $1.36. 95,762 shares of the company were exchanged, compared to its average volume of 20,989. The stock has a 50 day simple moving average of $1.73 and a 200-day simple moving average of $1.63. Marchex has a 1-year low of $1.15 and a 1-year high of $2.04. The firm has a market cap of $60.30 million, a price-to-earnings ratio of -11.33 and a beta of 1.86.

Marchex (NASDAQ:MCHX) last announced its quarterly earnings data on Wednesday, August 12th. The technology company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.03). The firm had revenue of $11.00 million for the quarter, compared to analysts’ expectations of $11.20 million. Marchex had a negative return on equity of 18.25% and a negative net margin of 12.44%.

Hedge Funds Weigh In On Marchex

A hedge fund recently bought a new stake in Marchex stock. Acuitas Investments LLC bought a new position in shares of Marchex, Inc. (NASDAQ:MCHX) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 133,702 shares of the technology company’s stock, valued at approximately $207,000. Marchex makes up 14.7% of Acuitas Investments LLC’s holdings, making the stock its 3rd largest position. Acuitas Investments LLC owned about 0.30% of Marchex at the end of the most recent reporting period. Hedge funds and other institutional investors own 73.46% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Marchex in a research note on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce”.

About Marchex

Marchex, Inc (NASDAQ: MCHX) is a conversation intelligence and analytics company that helps businesses understand and improve customer interactions. Its technology analyzes phone calls, text messages and other customer conversations to provide insights into marketing performance, lead quality, sales opportunities and service experiences.

The company offers solutions designed to help organizations acquire, engage and retain customers. Its products support call tracking, lead management, conversation analytics and artificial intelligence-powered analysis, enabling businesses to identify buying signals, evaluate customer interactions and improve operational and marketing decisions.

Marchex has historically focused on performance marketing and call-based analytics, evolving from its earlier digital marketing activities toward software and data solutions for businesses that rely on customer conversations.